首页 > 最新文献

Journal of Ophthalmic & Vision Research最新文献

英文 中文
Effect of Occupational Exposure to Low-frequency Electromagnetic Fields on Cataract Development. 职业接触低频电磁场对白内障发展的影响。
IF 1.5 Q3 OPHTHALMOLOGY Pub Date : 2025-04-25 eCollection Date: 2025-01-01 DOI: 10.18502/jovr.v20.12281
Mohammad Hosein Validad, Monireh Mahjoob, Masoud Pishjo, Mostafa Diani, Tahereh Rakhshandadi

Purpose: Cataracts are the second leading cause of visual impairment worldwide. This study aimed to examine the impact of occupational exposure to low-frequency electromagnetic fields on cataract development.

Methods: One hundred employees of Zahedan Electricity Company participated in this study. They were assigned to four groups based on their level of exposure: regular, operational, operator personnel, and non-exposure. Based on LOCS III grading, the risk of developing different types of cataracts (i.e., nuclear, posterior subcapsular, and cortical) was evaluated for all participants.

Results: The frequency of cataracts was 62.2% in the exposure group (which includes three subgroups: the regular, operational, and operator personnel) and 53.8% in the non-exposure group. There was a significant difference between the study groups in terms of nuclear opacity grading (P = 0.003). The correlation between nuclear and posterior subcapsular cataract grading and work experience duration in the exposure group was statistically significant (P < 0.018).

Conclusion: This study's findings indicate that exposure to low-frequency electromagnetic fields such as power lines, power plants, and power distribution posts may be a risk factor for cataract development, particularly nuclear cataracts.

目的:白内障是世界范围内视力损害的第二大原因。本研究旨在探讨职业接触低频电磁场对白内障发展的影响。方法:扎黑丹电力公司100名员工参与本研究。他们根据暴露程度被分为四组:普通、操作人员、操作人员和非暴露人员。根据LOCS III分级,评估所有参与者发生不同类型白内障(即核型、后囊下型和皮质型)的风险。结果:暴露组(包括常规、操作和操作人员三个亚组)白内障发生率为62.2%,非暴露组白内障发生率为53.8%。在核不透明分级方面,研究组之间存在显著差异(P = 0.003)。暴露组核性、后囊膜下白内障分级与工作经验的相关性有统计学意义(P 0.018)。结论:本研究结果表明,接触低频电磁场,如电力线、发电厂和配电站可能是白内障发展的危险因素,特别是核性白内障。
{"title":"Effect of Occupational Exposure to Low-frequency Electromagnetic Fields on Cataract Development.","authors":"Mohammad Hosein Validad, Monireh Mahjoob, Masoud Pishjo, Mostafa Diani, Tahereh Rakhshandadi","doi":"10.18502/jovr.v20.12281","DOIUrl":"10.18502/jovr.v20.12281","url":null,"abstract":"<p><strong>Purpose: </strong>Cataracts are the second leading cause of visual impairment worldwide. This study aimed to examine the impact of occupational exposure to low-frequency electromagnetic fields on cataract development.</p><p><strong>Methods: </strong>One hundred employees of Zahedan Electricity Company participated in this study. They were assigned to four groups based on their level of exposure: regular, operational, operator personnel, and non-exposure. Based on LOCS III grading, the risk of developing different types of cataracts (i.e., nuclear, posterior subcapsular, and cortical) was evaluated for all participants.</p><p><strong>Results: </strong>The frequency of cataracts was 62.2% in the exposure group (which includes three subgroups: the regular, operational, and operator personnel) and 53.8% in the non-exposure group. There was a significant difference between the study groups in terms of nuclear opacity grading (P = 0.003). The correlation between nuclear and posterior subcapsular cataract grading and work experience duration in the exposure group was statistically significant (P <math><mo><</mo></math> 0.018).</p><p><strong>Conclusion: </strong>This study's findings indicate that exposure to low-frequency electromagnetic fields such as power lines, power plants, and power distribution posts may be a risk factor for cataract development, particularly nuclear cataracts.</p>","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"20 ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12094108/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144119907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Practice, Challenges, and the Future of Ophthalmic Genetics in Saudi Arabia. 沙特阿拉伯眼科遗传学的临床实践、挑战和未来。
IF 1.5 Q3 OPHTHALMOLOGY Pub Date : 2025-04-02 eCollection Date: 2025-01-01 DOI: 10.18502/jovr.v20.15890
Basamat AlMoallem, Ghadah Alsuwailem, Nadeef Alqahtani, Layan Alshammari, Abeer Alkhodier

Purpose: Ophthalmic genetics is vital for diagnosing and managing inherited eye disorders, contributing to personalized treatments.

Methods: This cross-sectional study assessed 131 healthcare professionals in Saudi Arabia through an online questionnaire to evaluate clinical practices, referral patterns, and challenges in genetic ophthalmology.

Results: Our study showed that 61.7% of participants reported the availability of ophthalmic genetics services in their hospitals, with an equal percentage referring patients to genetic specialists. However, significant barriers were identified, including limited budgets for genetic testing (69.6%), a lack of trained physicians (70.9%), low community awareness (50.6%), and a perceived lack of treatment options (27.8%). Additionally, concerns about patient access to genetic testing (54.3%) and genetic counseling (50.6%) were highlighted.

Conclusion: This is the first study on ophthalmic genetics in Saudi Arabia, and its findings emphasize the need for policy reforms and targeted interventions. Proposed solutions include innovative financial models for genetic testing, expanded training programs for healthcare providers, and public awareness campaigns to improve access to genetic services. Addressing these challenges can enhance early diagnosis, treatment strategies, and patient outcomes in ophthalmic genetics.

目的:眼科遗传学对诊断和管理遗传性眼病至关重要,有助于个性化治疗。方法:本横断面研究通过在线问卷评估了沙特阿拉伯131名医疗保健专业人员的临床实践、转诊模式和遗传眼科面临的挑战。结果:我们的研究表明,61.7%的参与者报告了他们所在医院眼科遗传学服务的可用性,同样比例的患者转诊给遗传学专家。然而,发现了重大障碍,包括基因检测预算有限(69.6%),缺乏训练有素的医生(70.9%),社区意识低(50.6%),以及缺乏治疗选择(27.8%)。此外,对患者获得基因检测(54.3%)和遗传咨询(50.6%)的担忧被强调。结论:本研究首次在沙特阿拉伯进行眼科遗传学研究,其研究结果强调了政策改革和有针对性干预的必要性。提出的解决方案包括基因检测的创新财务模式、扩大医疗保健提供者的培训计划以及提高公众认识的运动,以改善获得基因服务的机会。解决这些挑战可以提高眼科遗传学的早期诊断、治疗策略和患者预后。
{"title":"Clinical Practice, Challenges, and the Future of Ophthalmic Genetics in Saudi Arabia.","authors":"Basamat AlMoallem, Ghadah Alsuwailem, Nadeef Alqahtani, Layan Alshammari, Abeer Alkhodier","doi":"10.18502/jovr.v20.15890","DOIUrl":"10.18502/jovr.v20.15890","url":null,"abstract":"<p><strong>Purpose: </strong>Ophthalmic genetics is vital for diagnosing and managing inherited eye disorders, contributing to personalized treatments.</p><p><strong>Methods: </strong>This cross-sectional study assessed 131 healthcare professionals in Saudi Arabia through an online questionnaire to evaluate clinical practices, referral patterns, and challenges in genetic ophthalmology.</p><p><strong>Results: </strong>Our study showed that 61.7% of participants reported the availability of ophthalmic genetics services in their hospitals, with an equal percentage referring patients to genetic specialists. However, significant barriers were identified, including limited budgets for genetic testing (69.6%), a lack of trained physicians (70.9%), low community awareness (50.6%), and a perceived lack of treatment options (27.8%). Additionally, concerns about patient access to genetic testing (54.3%) and genetic counseling (50.6%) were highlighted.</p><p><strong>Conclusion: </strong>This is the first study on ophthalmic genetics in Saudi Arabia, and its findings emphasize the need for policy reforms and targeted interventions. Proposed solutions include innovative financial models for genetic testing, expanded training programs for healthcare providers, and public awareness campaigns to improve access to genetic services. Addressing these challenges can enhance early diagnosis, treatment strategies, and patient outcomes in ophthalmic genetics.</p>","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"20 ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12013457/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144025902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Presumed Tubercular Multifocal Choroiditis. 推测为结核性多灶性脉络膜炎。
IF 1.6 Q3 OPHTHALMOLOGY Pub Date : 2024-12-31 eCollection Date: 2024-12-01 DOI: 10.18502/jovr.v19i4.11199
Masoud Soheilian, Pejvak Azadi

Purpose: To report a case of tubercular choroiditis that was initially treated for multifocal choroiditis.

Case report: A 54-year-old female patient diagnosed with multifocal choroiditis was referred to the clinic while undergoing treatment with systemic prednisone and methotrexate. The presenting visual acuity was 20/100 in the right eye and finger counting at 1 meter in the left eye. Further investigation by repeated tuberculin skin test and QuantiFERON-TB Gold test revealed tuberculosis as the probable cause of choroiditis. The patient was started on a four-drug antituberculosis regimen. Six months later, the vision improved significantly to 20/30 in the right eye and finger counting at 6 meters in the left eye, with no remaining cellular reaction.

Conclusion: Tuberculosis should be considered in the differential diagnosis of multifocal choroiditis, and it is vital to perform careful history taking and thorough examinations.

目的:报告一例结核性脉络膜炎,最初治疗为多灶性脉络膜炎。病例报告:一名54岁女性患者诊断为多灶性脉络膜炎,在接受全身强的松和甲氨蝶呤治疗时被转介到诊所。右眼视力20/100,左眼手指数1米。进一步的反复结核菌素皮肤试验和QuantiFERON-TB金试验显示结核可能是脉络膜炎的病因。病人开始接受四种药物的抗结核治疗。6个月后,右眼视力明显改善至20/30,左眼6米处手指计数,细胞反应消失。结论:多灶性脉络膜炎的鉴别诊断应考虑结核,仔细的病史记录和彻底的检查至关重要。
{"title":"Presumed Tubercular Multifocal Choroiditis.","authors":"Masoud Soheilian, Pejvak Azadi","doi":"10.18502/jovr.v19i4.11199","DOIUrl":"10.18502/jovr.v19i4.11199","url":null,"abstract":"<p><strong>Purpose: </strong>To report a case of tubercular choroiditis that was initially treated for multifocal choroiditis.</p><p><strong>Case report: </strong>A 54-year-old female patient diagnosed with multifocal choroiditis was referred to the clinic while undergoing treatment with systemic prednisone and methotrexate. The presenting visual acuity was 20/100 in the right eye and finger counting at 1 meter in the left eye. Further investigation by repeated tuberculin skin test and QuantiFERON-TB Gold test revealed tuberculosis as the probable cause of choroiditis. The patient was started on a four-drug antituberculosis regimen. Six months later, the vision improved significantly to 20/30 in the right eye and finger counting at 6 meters in the left eye, with no remaining cellular reaction.</p><p><strong>Conclusion: </strong>Tuberculosis should be considered in the differential diagnosis of multifocal choroiditis, and it is vital to perform careful history taking and thorough examinations.</p>","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"19 4","pages":"512-518"},"PeriodicalIF":1.6,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11795012/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143364625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacological Treatment of Presbyopia Using Pilocarpine 1.25% Eye Drops. 1.25%匹罗卡品滴眼液治疗老花眼的药理作用。
IF 1.6 Q3 OPHTHALMOLOGY Pub Date : 2024-12-31 eCollection Date: 2024-12-01 DOI: 10.18502/jovr.v19i4.14578
Seyed Abolghasem Mousavi, Zhale Rajavi, Hamideh Sabbaghi, Saeid Abdi, Nafeeseh Montazerin, Bahareh Kheiri, Azadeh Haseli-Mofrad, Kourosh Sheibani, Hemn Baghban Jaldian

Purpose: To assess the efficiency and safety of pilocarpine eye drop 1.25% analogue (IR- Pilo) in comparison with its original brand-name drug (Vuity).

Methods: In this non-randomized comparative study, 75 patients with presbyopia aged 40 to 60 years were enrolled. The right eyes of these patients received either IR-Pilo (n = 45) or Vuity (n = 30) and their contralateral eyes served as controls. Refractive errors, distance best-corrected visual acuity (BCVA), near vision, amplitude of accommodation, pupil size, and intraocular pressure (IOP) were measured before and 1 to 2 hours after instillation of the eye drop.

Results: The mean refractive error was stable, except for a small myopic shift in the Vuity group. There was no significant change in distance BCVA. Near vision improved significantly in both intervention groups (P < 0.001) with preference for IR-Pilo (4 vs 2.3). Furthermore, a higher amplitude of accommodation and pupil constriction occurred after instillation of both drops, with a higher effect associated with IR-Pilo. However, IOP did not change significantly post intervention.

Conclusion: IR-Pilo and Vuity eye drops had comparable results; both were effective and led to stable distance vision and improved near vision. Both ophthalmic drugs were safe and none of them were associated with significant adverse effects.

目的:评价匹罗卡品1.25%类似物滴眼液(IR- Pilo)与原品牌药(Vuity)的有效性和安全性。方法:在这项非随机对照研究中,纳入了75例年龄在40 ~ 60岁的老花眼患者。这些患者的右眼接受IR-Pilo (n = 45)或Vuity (n = 30),其对侧眼作为对照。在滴眼液前和滴眼后1 ~ 2小时测量屈光不正、距离最佳矫正视力(BCVA)、近视力、调节幅度、瞳孔大小和眼压(IOP)。结果:除屈光不正组有轻微的近视偏移外,屈光不正平均稳定。BCVA距离无明显变化。两个干预组的近视力均显著改善(P < 0.001), IR-Pilo优先(4 vs 2.3)。此外,在两种滴剂滴入后,瞳孔调节和收缩的幅度更高,与IR-Pilo相关的效果更高。然而,IOP在干预后没有明显变化。结论:IR-Pilo滴眼液与Vuity滴眼液效果相当;这两种方法都是有效的,并导致稳定的远视力和改善的近视力。这两种眼科药物都是安全的,没有明显的不良反应。
{"title":"Pharmacological Treatment of Presbyopia Using Pilocarpine 1.25% Eye Drops.","authors":"Seyed Abolghasem Mousavi, Zhale Rajavi, Hamideh Sabbaghi, Saeid Abdi, Nafeeseh Montazerin, Bahareh Kheiri, Azadeh Haseli-Mofrad, Kourosh Sheibani, Hemn Baghban Jaldian","doi":"10.18502/jovr.v19i4.14578","DOIUrl":"10.18502/jovr.v19i4.14578","url":null,"abstract":"<p><strong>Purpose: </strong>To assess the efficiency and safety of pilocarpine eye drop 1.25% analogue (IR- Pilo) in comparison with its original brand-name drug (Vuity).</p><p><strong>Methods: </strong>In this non-randomized comparative study, 75 patients with presbyopia aged 40 to 60 years were enrolled. The right eyes of these patients received either IR-Pilo (<i>n</i> = 45) or Vuity (<i>n</i> = 30) and their contralateral eyes served as controls. Refractive errors, distance best-corrected visual acuity (BCVA), near vision, amplitude of accommodation, pupil size, and intraocular pressure (IOP) were measured before and 1 to 2 hours after instillation of the eye drop.</p><p><strong>Results: </strong>The mean refractive error was stable, except for a small myopic shift in the Vuity group. There was no significant change in distance BCVA. Near vision improved significantly in both intervention groups (<i>P</i> <math><mo><</mo></math> 0.001) with preference for IR-Pilo (4 vs 2.3). Furthermore, a higher amplitude of accommodation and pupil constriction occurred after instillation of both drops, with a higher effect associated with IR-Pilo. However, IOP did not change significantly post intervention.</p><p><strong>Conclusion: </strong>IR-Pilo and Vuity eye drops had comparable results; both were effective and led to stable distance vision and improved near vision. Both ophthalmic drugs were safe and none of them were associated with significant adverse effects.</p>","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"19 4","pages":"468-475"},"PeriodicalIF":1.6,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11795009/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143364524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term Results of Topical Insulin Treatment for Persistent Corneal Epithelial Defects. 外用胰岛素治疗持续性角膜上皮缺损的远期疗效。
IF 1.6 Q3 OPHTHALMOLOGY Pub Date : 2024-12-31 eCollection Date: 2024-12-01 DOI: 10.18502/jovr.v19i4.13977
Júlio Almeida, Tomás R Costa, Maria Vivas, Catarina Monteiro, Fernando T Vaz, Diana Silva, Cristina Vendrell, Isabel Prieto

Purpose: To evaluate the effects of topical insulin in patients with persistent corneal epithelial defects that are refractory to the standard treatment.

Methods: A retrospective, hospital-based, clinical study was performed on 17 eyes of 16 patients with different types of refractory persistent epithelial defects who were treated with topical insulin. The treatment was continued until the defect either was resolved or persisted after three months. Patients' demographic information, etiology, comorbidities, and clinical data were reviewed. The rate of epithelial healing was considered as the primary outcome measure.

Results: Neurotrophic keratitis was the most common cause of persistent epithelial defects (58.8%), and within this category, herpetic eye disease was the main comorbidity (44.4%). The mean follow-up time was 17.91 months. Eleven out of fifteen eyes (77.3%) had complete improvement and only one patient did not respond to the treatment. The mean time of reepithelization for the eyes with full recovery was 31.27 days (ranging from 6 to 61 days). The best-corrected visual acuity improved significantly after treatment (P < 0.005), and there were no reports of complications or side effects during the study period.

Conclusion: Our results suggest that topical insulin, due to its good safety profile, availability, and affordability, could be a good therapeutic alternative for persistent epithelial defects.

目的:评价外用胰岛素治疗标准治疗难治性持续性角膜上皮缺损患者的效果。方法:回顾性、以医院为基础的临床研究,对16例不同类型难治性持续性上皮缺损患者17眼进行外用胰岛素治疗。治疗继续进行,直到三个月后缺陷消失或持续存在。回顾了患者的人口统计信息、病因、合并症和临床资料。上皮愈合率被认为是主要的结局指标。结果:神经营养性角膜炎是持续性上皮缺损最常见的原因(58.8%),在这一类别中,疱疹性眼病是主要的合并症(44.4%)。平均随访时间17.91个月。15只眼睛中有11只(77.3%)完全改善,只有1名患者对治疗无反应。完全恢复的眼平均再上皮时间为31.27天(6 ~ 61天)。治疗后最佳矫正视力明显提高(P < 0.005),研究期间无并发症和不良反应报告。结论:我们的研究结果表明,外用胰岛素由于其良好的安全性、可获得性和可负担性,可能是治疗持续性上皮缺陷的良好选择。
{"title":"Long-term Results of Topical Insulin Treatment for Persistent Corneal Epithelial Defects.","authors":"Júlio Almeida, Tomás R Costa, Maria Vivas, Catarina Monteiro, Fernando T Vaz, Diana Silva, Cristina Vendrell, Isabel Prieto","doi":"10.18502/jovr.v19i4.13977","DOIUrl":"10.18502/jovr.v19i4.13977","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the effects of topical insulin in patients with persistent corneal epithelial defects that are refractory to the standard treatment.</p><p><strong>Methods: </strong>A retrospective, hospital-based, clinical study was performed on 17 eyes of 16 patients with different types of refractory persistent epithelial defects who were treated with topical insulin. The treatment was continued until the defect either was resolved or persisted after three months. Patients' demographic information, etiology, comorbidities, and clinical data were reviewed. The rate of epithelial healing was considered as the primary outcome measure.</p><p><strong>Results: </strong>Neurotrophic keratitis was the most common cause of persistent epithelial defects (58.8%), and within this category, herpetic eye disease was the main comorbidity (44.4%). The mean follow-up time was 17.91 months. Eleven out of fifteen eyes (77.3%) had complete improvement and only one patient did not respond to the treatment. The mean time of reepithelization for the eyes with full recovery was 31.27 days (ranging from 6 to 61 days). The best-corrected visual acuity improved significantly after treatment (<i>P</i> <math><mo><</mo></math> 0.005), and there were no reports of complications or side effects during the study period.</p><p><strong>Conclusion: </strong>Our results suggest that topical insulin, due to its good safety profile, availability, and affordability, could be a good therapeutic alternative for persistent epithelial defects.</p>","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"19 4","pages":"397-404"},"PeriodicalIF":1.6,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11795001/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143364470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Sight for Old: Commentary On the Use of Pilocarpine for Presbyopia. 以旧换新:匹罗卡品治疗老花眼述评。
IF 1.6 Q3 OPHTHALMOLOGY Pub Date : 2024-12-31 eCollection Date: 2024-12-01 DOI: 10.18502/jovr.v19i4.17786
Cameron F Parsa
{"title":"New Sight for Old: Commentary On the Use of Pilocarpine for Presbyopia.","authors":"Cameron F Parsa","doi":"10.18502/jovr.v19i4.17786","DOIUrl":"10.18502/jovr.v19i4.17786","url":null,"abstract":"","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"19 4","pages":"392-396"},"PeriodicalIF":1.6,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11795007/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143364520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum Oxidative Stress-related Biomarkers in Ocular Hypertension and Glaucoma. 高眼压和青光眼的血清氧化应激相关生物标志物。
IF 1.6 Q3 OPHTHALMOLOGY Pub Date : 2024-12-31 eCollection Date: 2024-12-01 DOI: 10.18502/jovr.v19i4.15011
Mine Esen Baris, Onur Furundaoturan, Meltem Kocamanoğlu, Seray Şahin, Yasemin Akçay, Suzan Güven Yılmaz

Purpose: To evaluate the serum levels of oxidative stress-related molecules in patients with ocular hypertension (OHT) and primary open-angle glaucoma (POAG) compared with healthy controls.

Methods: Treatment-naive patients with no known systemic diseases and with OHTand POAG diagnosis were recruited for the study. Also, age- and gender-matched healthy volunteers with no ocular and systemic diseases were included as controls. None of the participants were under any topical or systemic treatment or vitamin/antioxidant supplements. Smokers were excluded from the study. Serum levels of total antioxidant capacity (TAC), ascorbic acid, protein carbonyls (PCs), advanced glycation end products (AGEs), neuronal pentraxin 2 (NPTX2), and β -amyloid precursor protein(A β ) were analyzed.

Results: A total of 90 patients (30 in each group) were included in the study. There was no statistically significant difference between the study groups in terms of age and gender distribution. Serum levels of TAC (1.47 ± 0.11 mmole/L) were significantly higher in patients with OHT compared to controls (1.40 ± 0.11 mmole/L) and patients with POAG (1.30 ± 0.08 mmole/L) (P < 0.05). However, there was no significant difference between the study groups in terms of serum levels of ascorbic acid, PCs, AGEs, NPTX2, and A β .

Conclusion: Serum levels of TAC were significantly higher in patients with OHT. This elevated level might contribute to the protection of the optic nerve even in the presence of increased intraocular pressure.

目的:评价高眼压(OHT)和原发性开角型青光眼(POAG)患者血清氧化应激相关分子水平与健康对照的差异。方法:招募未接受治疗、无已知全身性疾病且OHTand POAG诊断的患者进行研究。此外,年龄和性别匹配、无眼部和全身性疾病的健康志愿者也被纳入对照组。没有参与者接受任何局部或全身治疗或维生素/抗氧化剂补充剂。吸烟者被排除在研究之外。分析血清总抗氧化能力(TAC)、抗坏血酸、蛋白羰基(PCs)、晚期糖基化终产物(AGEs)、神经元戊烷素2 (NPTX2)和β -淀粉样蛋白前体蛋白(A β)水平。结果:共纳入90例患者,每组30例。在年龄和性别分布方面,研究组之间没有统计学上的显著差异。OHT患者血清TAC水平(1.47±0.11 mmol /L)明显高于对照组(1.40±0.11 mmol /L)和POAG患者(1.30±0.08 mmol /L) (P < 0.05)。然而,在血清抗坏血酸、PCs、AGEs、NPTX2和A β水平方面,研究组之间无显著差异。结论:OHT患者血清TAC水平显著升高。这种升高的水平可能有助于视神经的保护,即使在眼压升高的情况下。
{"title":"Serum Oxidative Stress-related Biomarkers in Ocular Hypertension and Glaucoma.","authors":"Mine Esen Baris, Onur Furundaoturan, Meltem Kocamanoğlu, Seray Şahin, Yasemin Akçay, Suzan Güven Yılmaz","doi":"10.18502/jovr.v19i4.15011","DOIUrl":"10.18502/jovr.v19i4.15011","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the serum levels of oxidative stress-related molecules in patients with ocular hypertension (OHT) and primary open-angle glaucoma (POAG) compared with healthy controls.</p><p><strong>Methods: </strong>Treatment-naive patients with no known systemic diseases and with OHTand POAG diagnosis were recruited for the study. Also, age- and gender-matched healthy volunteers with no ocular and systemic diseases were included as controls. None of the participants were under any topical or systemic treatment or vitamin/antioxidant supplements. Smokers were excluded from the study. Serum levels of total antioxidant capacity (TAC), ascorbic acid, protein carbonyls (PCs), advanced glycation end products (AGEs), neuronal pentraxin 2 (NPTX2), and <math><mi>β</mi></math> -amyloid precursor protein(A <math><mi>β</mi></math> ) were analyzed.</p><p><strong>Results: </strong>A total of 90 patients (30 in each group) were included in the study. There was no statistically significant difference between the study groups in terms of age and gender distribution. Serum levels of TAC (1.47 <math><mo>±</mo></math> 0.11 mmole/L) were significantly higher in patients with OHT compared to controls (1.40 <math><mo>±</mo></math> 0.11 mmole/L) and patients with POAG (1.30 <math><mo>±</mo></math> 0.08 mmole/L) (<i>P</i> <math><mo><</mo></math> 0.05). However, there was no significant difference between the study groups in terms of serum levels of ascorbic acid, PCs, AGEs, NPTX2, and A <math><mi>β</mi></math> .</p><p><strong>Conclusion: </strong>Serum levels of TAC were significantly higher in patients with OHT. This elevated level might contribute to the protection of the optic nerve even in the presence of increased intraocular pressure.</p>","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"19 4","pages":"433-439"},"PeriodicalIF":1.6,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11795014/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143364940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sequential Serous Choroidal Detachment in Subjects Undergoing Bilateral Trabeculectomy. 接受双侧小梁切除术的受试者的顺序浆液性脉络膜脱离。
IF 1.6 Q3 OPHTHALMOLOGY Pub Date : 2024-12-31 eCollection Date: 2024-12-01 DOI: 10.18502/jovr.v19i4.13881
Maryam Yadgari, Kiana Hassanpour, Fatemeh Vafaei, Nina Firoozian, Maryam Oraee Yazdani, Zahra Khorrami, Sadid Hooshmandi

Purpose: This study aims to assess the incidence of serous choroidal detachment (SCD) in the second eye of patients undergoing bilateral trabeculectomy (BT) and evaluate its impact on the clinical outcomes and failure rate of trabeculectomy in the second-operated eyes.

Methods: This retrospective case-control study analyzed 90 eyes of 45 patients who underwent BT. Surgical success was defined as maintaining intraocular pressure (IOP) between 5 and 21 mmHg, requiring no additional glaucoma surgery, and exhibiting a visual acuity of at least light perception. Relevant patient data, such as age, glaucoma type, systemic diseases, preoperative and postoperative IOP, and complications, were extracted from medical records.

Results: The mean age of patients was 59.8 ± 11.1 years. The five-year cumulative probability of success in the first- and second-operated eyes was 61.0% and 67.6%, respectively (log rank = 0.085, P = 0.77). Among the participants, 28.9% experienced SCD, and 76.9% of those who had SCD in the first-operated eye developed the same condition in the second eye as well (P < 0.001). In the first-operated eyes, the five-year cumulative probability of survival was 71.7% without SCD and 35.0% with SCD (log rank = 2.59, P = 0.107).

Conclusion: The occurrence of SCD in the first eye following trabeculectomy may indicate a predisposition to its development in the second eye during BT. Furthermore, the surgical success rate of the second-operated eye is comparable to the outcomes of the first eye undergoing BT.

目的:本研究旨在评估双侧小梁切除术(BT)患者第二眼浆液性脉络膜脱离(SCD)的发生率,并评估其对第二眼小梁切除术临床结局和失败率的影响。方法:本回顾性病例对照研究分析了45例接受BT手术的90只眼,手术成功的定义是维持眼压(IOP)在5 - 21 mmHg之间,不需要额外的青光眼手术,并表现出至少光感知的视力。从病历中提取患者的相关资料,如年龄、青光眼类型、全身性疾病、术前术后IOP、并发症等。结果:患者平均年龄59.8±11.1岁。第一次和第二次手术的5年累计成功率分别为61.0%和67.6% (log rank = 0.085, P = 0.77)。在参与者中,28.9%的人经历了SCD, 76.9%的第一次手术眼发生SCD的人在第二眼也发生了同样的情况(P < 0.001)。在首次手术的眼睛中,无SCD的5年累积生存率为71.7%,有SCD的为35.0% (log rank = 2.59, P = 0.107)。结论:小梁切除术后第1只眼发生SCD,可能提示手术过程中第2只眼更易发生SCD,且第2只眼手术成功率与第1只眼手术成功率相当。
{"title":"Sequential Serous Choroidal Detachment in Subjects Undergoing Bilateral Trabeculectomy.","authors":"Maryam Yadgari, Kiana Hassanpour, Fatemeh Vafaei, Nina Firoozian, Maryam Oraee Yazdani, Zahra Khorrami, Sadid Hooshmandi","doi":"10.18502/jovr.v19i4.13881","DOIUrl":"10.18502/jovr.v19i4.13881","url":null,"abstract":"<p><strong>Purpose: </strong>This study aims to assess the incidence of serous choroidal detachment (SCD) in the second eye of patients undergoing bilateral trabeculectomy (BT) and evaluate its impact on the clinical outcomes and failure rate of trabeculectomy in the second-operated eyes.</p><p><strong>Methods: </strong>This retrospective case-control study analyzed 90 eyes of 45 patients who underwent BT. Surgical success was defined as maintaining intraocular pressure (IOP) between 5 and 21 mmHg, requiring no additional glaucoma surgery, and exhibiting a visual acuity of at least light perception. Relevant patient data, such as age, glaucoma type, systemic diseases, preoperative and postoperative IOP, and complications, were extracted from medical records.</p><p><strong>Results: </strong>The mean age of patients was 59.8 <math><mo>±</mo></math> 11.1 years. The five-year cumulative probability of success in the first- and second-operated eyes was 61.0% and 67.6%, respectively (log rank = 0.085, <i>P</i> = 0.77). Among the participants, 28.9% experienced SCD, and 76.9% of those who had SCD in the first-operated eye developed the same condition in the second eye as well (<i>P</i> <math><mo><</mo></math> 0.001). In the first-operated eyes, the five-year cumulative probability of survival was 71.7% without SCD and 35.0% with SCD (log rank = 2.59, <i>P</i> = 0.107).</p><p><strong>Conclusion: </strong>The occurrence of SCD in the first eye following trabeculectomy may indicate a predisposition to its development in the second eye during BT. Furthermore, the surgical success rate of the second-operated eye is comparable to the outcomes of the first eye undergoing BT.</p>","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"19 4","pages":"421-432"},"PeriodicalIF":1.6,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11795004/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143364931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Choroidal and Retinal OCTA Parameters after Scleral Buckling. 巩膜屈曲后脉络膜和视网膜OCTA参数。
IF 1.6 Q3 OPHTHALMOLOGY Pub Date : 2024-12-31 eCollection Date: 2024-12-01 DOI: 10.18502/jovr.v19i4.14432
Siamak Moradian, Mahmoud Dehghan, Morteza Borandeh Seifi, Mohsen Dastmardi, Fatemeh Suri

Purpose: To evaluate choroidal structure and vasculature in eyes following scleral buckling (SB) for rhegmatogenous retinal detachment (RRD) compared with fellow eyes and control eyes.

Methods: This retrospective observational study was performed on 84 eyes: 32 eyes in the study group consisting of patients who had undergone SB due to RRD, 32 fellow eyes of the same patients, and 20 normal control eyes. Choroidal structures and optical coherence tomography angiography (OCTA) parameters were measured and compared among the three study groups.

Results: In the study group, the mean total choroidal area (0.6816 ± 0.03188 mm2) was comparable to the fellow eyes (0.7199 ± 0.03056 mm2) and the control group (0.7154 ± 0.17160 mm2). Mean outer luminal area was significantly lower in the study group (0.4089 ± 0.00442 mm2) than in the fellow eyes (0.4437 ± 0.00701 mm2) and the control group (0.4475 ± 0.00442 mm2) (P = 0.042, and 0.047, respectively). The choroidal vascularity index (CVI) and OCTA parameters were not significantly different in eyes with prior SB compared to the fellow eyes and the control group.

Conclusion: SB does not significantly affect CVI, choroidal vasculature, and OCTA parameters.

目的:评价孔源性视网膜脱离(RRD)巩膜屈曲(SB)术后眼内脉络膜结构和血管的变化,并与正常眼和对照眼进行比较。方法:84只眼进行回顾性观察研究,其中研究组32只眼为因RRD而行SB的患者,32只眼为同组患者,20只眼为正常对照。测量并比较三个研究组的脉络膜结构和光学相干断层血管造影(OCTA)参数。结果:研究组的平均脉络膜总面积(0.6816±0.03188 mm2)与对照组(0.7199±0.03056 mm2)和对照组(0.7154±0.17160 mm2)相当。研究组平均外腔面积(0.4089±0.00442 mm2)明显低于对照组(0.4437±0.00701 mm2)和对照组(0.4475±0.00442 mm2) (P分别为0.042和0.047)。与正常眼和对照组相比,既往SB眼的脉络膜血管指数(CVI)和OCTA参数无显著差异。结论:SB对CVI、脉络膜血管和OCTA参数无明显影响。
{"title":"Choroidal and Retinal OCTA Parameters after Scleral Buckling.","authors":"Siamak Moradian, Mahmoud Dehghan, Morteza Borandeh Seifi, Mohsen Dastmardi, Fatemeh Suri","doi":"10.18502/jovr.v19i4.14432","DOIUrl":"10.18502/jovr.v19i4.14432","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate choroidal structure and vasculature in eyes following scleral buckling (SB) for rhegmatogenous retinal detachment (RRD) compared with fellow eyes and control eyes.</p><p><strong>Methods: </strong>This retrospective observational study was performed on 84 eyes: 32 eyes in the study group consisting of patients who had undergone SB due to RRD, 32 fellow eyes of the same patients, and 20 normal control eyes. Choroidal structures and optical coherence tomography angiography (OCTA) parameters were measured and compared among the three study groups.</p><p><strong>Results: </strong>In the study group, the mean total choroidal area (0.6816 <math><mo>±</mo></math> 0.03188 mm<sup>2</sup>) was comparable to the fellow eyes (0.7199 <math><mo>±</mo></math> 0.03056 mm<sup>2</sup>) and the control group (0.7154 <math><mo>±</mo></math> 0.17160 mm<sup>2</sup>). Mean outer luminal area was significantly lower in the study group (0.4089 <math><mo>±</mo></math> 0.00442 mm<sup>2</sup>) than in the fellow eyes (0.4437 <math><mo>±</mo></math> 0.00701 mm<sup>2</sup>) and the control group (0.4475 <math><mo>±</mo></math> 0.00442 mm<sup>2</sup>) (<i>P</i> = 0.042, and 0.047, respectively). The choroidal vascularity index (CVI) and OCTA parameters were not significantly different in eyes with prior SB compared to the fellow eyes and the control group.</p><p><strong>Conclusion: </strong>SB does not significantly affect CVI, choroidal vasculature, and OCTA parameters.</p>","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"19 4","pages":"440-448"},"PeriodicalIF":1.6,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11795003/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143364541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Three Inferior Oblique Weakening Procedures for Management of Mild Hypertropia in Unilateral Superior Oblique Muscle Palsy. 三种下斜肌弱化术治疗单侧上斜肌麻痹轻度斜视。
IF 1.6 Q3 OPHTHALMOLOGY Pub Date : 2024-12-31 eCollection Date: 2024-12-01 DOI: 10.18502/jovr.v19i4.14394
Hajar Farvardin, Fatemeh Ebrahimi, Mohammadreza Talebnejad, Hadi Farvardin, Alireza Attar, Majid Farvardin

Purpose: To investigate the surgical outcomes of three different types of inferior oblique muscle weakening procedures in patients with mild hypertropia due to unilateral superior oblique muscle palsy.

Methods: We reviewed surgical data of patients aged > 30 years with unilateral superior oblique palsy. The patients were categorized into three groups in terms of the surgical procedure: inferior oblique myectomy (IOM), inferior oblique recession (IOR), and inferior oblique disinsertion (IOD). Patients with preoperative hypertropia of 6 to 10 prism diopters (PD) were selected as mild cases for further comparison. Demographic data, preoperative and postoperative deviations in the primary position, contralateral gaze, contralateral elevation gaze, and ipsilateral tilt were considered for analysis. Complete success was defined as achieving postoperative orthotropia in addition to the resolution of diplopia and head tilt.

Results: A total of 82 patients with an average age of 11.8 years were included in this study. The male-to-female ratio was 1.27, and the most common cause of palsy was congenital (89%). Fifty-six patients were treated with IOM, thirteen with IOR, and thirteen with IOD. The mean hypertropia correction was significantly better in the IOM group (9.1 PD) than in the IOR (7.1 PD) and IOD (7.5 PD) groups. Complete success was achieved in 80.3% of the IOM group, 69.2% of the IOR group, and 84.6% of the IOD group. The reoperation rate was 1.7% in the IOM group and 7.6% in the IOR group.

Conclusion: Compared to IOR and IOD procedures, IOM was more effective in correcting hypertropia in patients with inferior oblique muscle overaction and mild hypertropia secondary to unilateral superior oblique palsy.

目的:探讨三种不同类型下斜肌弱化术治疗单侧上斜肌麻痹所致轻度斜视的手术效果。方法:回顾50 ~ 30岁单侧上斜肌麻痹患者的手术资料。根据手术方式将患者分为三组:下斜肌切除术(IOM),下斜肌退缩(IOR)和下斜肌拔出(IOD)。术前6 ~ 10棱镜屈光度(PD)的患者作为轻度病例进一步比较。人口统计数据、术前和术后原发位置偏差、对侧凝视、对侧仰视和同侧倾斜均被纳入分析。完全成功被定义为除复视和头部倾斜的解决外实现术后正斜视。结果:本研究共纳入82例患者,平均年龄11.8岁。男女比例为1.27,最常见的麻痹原因为先天性(89%)。56例患者采用IOM, 13例采用IOR, 13例采用IOD。IOM组的平均斜视矫正效果(9.1 PD)明显优于IOR组(7.1 PD)和IOD组(7.5 PD)。IOM组的成功率为80.3%,IOR组为69.2%,IOD组为84.6%。IOM组再手术率1.7%,IOR组再手术率7.6%。结论:与IOR和IOD手术相比,IOM手术对单侧上斜肌麻痹继发的下斜肌过度活动和轻度斜视患者的斜视矫正更为有效。
{"title":"Three Inferior Oblique Weakening Procedures for Management of Mild Hypertropia in Unilateral Superior Oblique Muscle Palsy.","authors":"Hajar Farvardin, Fatemeh Ebrahimi, Mohammadreza Talebnejad, Hadi Farvardin, Alireza Attar, Majid Farvardin","doi":"10.18502/jovr.v19i4.14394","DOIUrl":"10.18502/jovr.v19i4.14394","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the surgical outcomes of three different types of inferior oblique muscle weakening procedures in patients with mild hypertropia due to unilateral superior oblique muscle palsy.</p><p><strong>Methods: </strong>We reviewed surgical data of patients aged <math><mo>></mo></math> 30 years with unilateral superior oblique palsy. The patients were categorized into three groups in terms of the surgical procedure: inferior oblique myectomy (IOM), inferior oblique recession (IOR), and inferior oblique disinsertion (IOD). Patients with preoperative hypertropia of 6 to 10 prism diopters (PD) were selected as mild cases for further comparison. Demographic data, preoperative and postoperative deviations in the primary position, contralateral gaze, contralateral elevation gaze, and ipsilateral tilt were considered for analysis. Complete success was defined as achieving postoperative orthotropia in addition to the resolution of diplopia and head tilt.</p><p><strong>Results: </strong>A total of 82 patients with an average age of 11.8 years were included in this study. The male-to-female ratio was 1.27, and the most common cause of palsy was congenital (89%). Fifty-six patients were treated with IOM, thirteen with IOR, and thirteen with IOD. The mean hypertropia correction was significantly better in the IOM group (9.1 PD) than in the IOR (7.1 PD) and IOD (7.5 PD) groups. Complete success was achieved in 80.3% of the IOM group, 69.2% of the IOR group, and 84.6% of the IOD group. The reoperation rate was 1.7% in the IOM group and 7.6% in the IOR group.</p><p><strong>Conclusion: </strong>Compared to IOR and IOD procedures, IOM was more effective in correcting hypertropia in patients with inferior oblique muscle overaction and mild hypertropia secondary to unilateral superior oblique palsy.</p>","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"19 4","pages":"459-467"},"PeriodicalIF":1.6,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11795008/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143364944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Ophthalmic & Vision Research
全部 Geobiology Appl. Clay Sci. Geochim. Cosmochim. Acta J. Hydrol. Org. Geochem. Carbon Balance Manage. Contrib. Mineral. Petrol. Int. J. Biometeorol. IZV-PHYS SOLID EART+ J. Atmos. Chem. Acta Oceanolog. Sin. Acta Geophys. ACTA GEOL POL ACTA PETROL SIN ACTA GEOL SIN-ENGL AAPG Bull. Acta Geochimica Adv. Atmos. Sci. Adv. Meteorol. Am. J. Phys. Anthropol. Am. J. Sci. Am. Mineral. Annu. Rev. Earth Planet. Sci. Appl. Geochem. Aquat. Geochem. Ann. Glaciol. Archaeol. Anthropol. Sci. ARCHAEOMETRY ARCT ANTARCT ALP RES Asia-Pac. J. Atmos. Sci. ATMOSPHERE-BASEL Atmos. Res. Aust. J. Earth Sci. Atmos. Chem. Phys. Atmos. Meas. Tech. Basin Res. Big Earth Data BIOGEOSCIENCES Geostand. Geoanal. Res. GEOLOGY Geosci. J. Geochem. J. Geochem. Trans. Geosci. Front. Geol. Ore Deposits Global Biogeochem. Cycles Gondwana Res. Geochem. Int. Geol. J. Geophys. Prospect. Geosci. Model Dev. GEOL BELG GROUNDWATER Hydrogeol. J. Hydrol. Earth Syst. Sci. Hydrol. Processes Int. J. Climatol. Int. J. Earth Sci. Int. Geol. Rev. Int. J. Disaster Risk Reduct. Int. J. Geomech. Int. J. Geog. Inf. Sci. Isl. Arc J. Afr. Earth. Sci. J. Adv. Model. Earth Syst. J APPL METEOROL CLIM J. Atmos. Oceanic Technol. J. Atmos. Sol. Terr. Phys. J. Clim. J. Earth Sci. J. Earth Syst. Sci. J. Environ. Eng. Geophys. J. Geog. Sci. Mineral. Mag. Miner. Deposita Mon. Weather Rev. Nat. Hazards Earth Syst. Sci. Nat. Clim. Change Nat. Geosci. Ocean Dyn. Ocean and Coastal Research npj Clim. Atmos. Sci. Ocean Modell. Ocean Sci. Ore Geol. Rev. OCEAN SCI J Paleontol. J. PALAEOGEOGR PALAEOCL PERIOD MINERAL PETROLOGY+ Phys. Chem. Miner. Polar Sci. Prog. Oceanogr. Quat. Sci. Rev. Q. J. Eng. Geol. Hydrogeol. RADIOCARBON Pure Appl. Geophys. Resour. Geol. Rev. Geophys. Sediment. Geol.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1